Jung-Chi Hsu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jung-Chi Hsu has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Shu-Lin Chuang
Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan
8 shared publicationsLian-Yu Lin
Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, Yunlin Branch, Yunlin, Taiwan
6 shared publicationsYen-Yun Yang
Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan
6 shared publications- Lian-Yu Lin
National Taiwan University College of Medicine and Hospital
5 shared publications - Chih-Hsien Wang
Cardiovascular Surgery, Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan
3 shared publications - Yih-Sharng Chen
National Taiwan University Hospital
3 shared publications
Latest Publications
- Open Access
- 6 May 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (7) , 1274-1277
Prognostic Significance of CT-Derived Pectoralis Muscle Phenotypes in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation Support
- 6 May 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (7) , 1274-1277
Open AccessPrognostic Significance of CT-Derived Pectoralis Muscle Phenotypes in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation Support
- Open Access
- 5 May 2026
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (3)
Stratifying prognosis in heart failure patients with reduced ejection fraction and atrial cardiomyopathy
Aims: Co-existence of atrial cardiomyopathy (AtCM) and heart failure with reduced ejection fraction (HFrEF) has prognostic implications. We aimed to quantify the association of a health records data biomarker, FIND-AF, with outcomes in patients with HFrEF and AtCM without atrial fibrillation (AF). Methods: Patients with HFrEF and AtCM without AF at baseline were identified from the ECG-HF registry (2010–6) and linked to the territory-wide Clinical Data Analysis and Reporting System. AtCM was operationalized using a pragmatic multi-domain framework based on the 2025 clinical consensus statement of the Heart Failure Association of the ESC, using electrocardiographic and echocardiographic parameters. Patients were stratified into high and low risk by sex-specific FIND-AF thresholds. The primary outcome was a composite of incident AF, ischaemic stroke, and all-cause mortality. All patients were followed until 31 December 2019. Results: We included 164 patients (mean age 62.3 ± 13.0 years, 73.8% men). The primary outcome occurred in 23/32 (71.9%) high-risk vs 67/132 (50.8%) low-risk patients (OR 2.48, 95% CI 1.07–5.76; P = .035). In the model including both FIND-AF risk group and AtCM severity, high FIND-AF risk remained associated with the composite outcome (adjusted OR 2.70, 95% CI 1.14–6.40; P = .024). Compared with CHA2DS2-VASc, FIND-AF showed superior discrimination for the composite outcome (AUC .735 vs .641; DeLong P = .007) and ischaemic stroke (AUC .700 vs .575; DeLong P = .008). Conclusions: High FIND-AF risk is associated with adverse prognosis in a cohort of patients with HFrEF and AtCM but without baseline AF. These exploratory data require external validation and a prospective study.
- 5 May 2026
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (3)
Open AccessStratifying prognosis in heart failure patients with reduced ejection fraction and atrial cardiomyopathy
Aims: Co-existence of atrial cardiomyopathy (AtCM) and heart failure with reduced ejection fraction (HFrEF) has prognostic implications. We aimed to quantify the association of a health records data biomarker, FIND-AF, with outcomes in patients with HFrEF and AtCM without atrial fibrillation (AF). Methods: Patients with HFrEF and AtCM without AF at baseline were identified from the ECG-HF registry (2010–6) and linked to the territory-wide Clinical Data Analysis and Reporting System. AtCM was operationalized using a pragmatic multi-domain framework based on the 2025 clinical consensus statement of the Heart Failure Association of the ESC, using electrocardiographic and echocardiographic parameters. Patients were stratified into high and low risk by sex-specific FIND-AF thresholds. The primary outcome was a composite of incident AF, ischaemic stroke, and all-cause mortality. All patients were followed until 31 December 2019. Results: We included 164 patients (mean age 62.3 ± 13.0 years, 73.8% men). The primary outcome occurred in 23/32 (71.9%) high-risk vs 67/132 (50.8%) low-risk patients (OR 2.48, 95% CI 1.07–5.76; P = .035). In the model including both FIND-AF risk group and AtCM severity, high FIND-AF risk remained associated with the composite outcome (adjusted OR 2.70, 95% CI 1.14–6.40; P = .024). Compared with CHA2DS2-VASc, FIND-AF showed superior discrimination for the composite outcome (AUC .735 vs .641; DeLong P = .007) and ischaemic stroke (AUC .700 vs .575; DeLong P = .008). Conclusions: High FIND-AF risk is associated with adverse prognosis in a cohort of patients with HFrEF and AtCM but without baseline AF. These exploratory data require external validation and a prospective study.
- Open Access
- 5 May 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (5) , 794-808
Cardio-Kidney-Metabolic Phenotypes and Adverse Clinical Outcomes in Patients With Atrial Fibrillation
- 5 May 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (5) , 794-808
Open AccessCardio-Kidney-Metabolic Phenotypes and Adverse Clinical Outcomes in Patients With Atrial Fibrillation
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (13) , e039541
Sex Differences in In‐Hospital Mortality Among Patients Receiving Veno‐Arterial Extracorporeal Membrane Oxygenation and Extracorporeal Cardiopulmonary Resuscitation: A Propensity Score‐Matched Analysis
Background: Veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) is used in cardiogenic shock, but sex‐specific outcomes remain unclear. This study investigated in‐hospital mortality differences by sex among patients receiving extracorporeal cardiopulmonary resuscitation (ECPR). Methods: We retrospectively reviewed adults with cardiogenic shock treated with VA‐ECMO at National Taiwan University Hospital between 2010 and 2021. After propensity score matching to improve comparability between groups, survival outcomes were assessed using Kaplan‐Meier estimates, and Cox proportional hazards models were used to evaluate the effect of sex on in‐hospital mortality. Results: Of the 1329 patients (average age: 57.1±15.0 years; 953 men), 670 underwent VA‐ECMO for ECPR. Women in the VA‐ECMO group exhibited a lower prevalence of out‐of‐hospital cardiac arrest (6.7% versus 10.7%, P =0.031), a lower body mass index (24.0±4.4 versus 25.0±4.3, P P =0.017) and coronary artery disease (20.9% versus 28.6%, P =0.005) after propensity score matching. No discernible sex differences were observed in the baseline characteristics of the ECPR subgroup. Kaplan‐Meier analyses showed no significant sex differences in mortality for VA‐ECMO (log‐rank P =0.1), but significant disparities were noted for ECPR (log‐rank P =0.006). In the ECPR group, female patients exhibited higher mortality rates compared with men (hazard ratio, 1.37 [95% CI, 1.09–1.72]; P =0.007), independent of Survival After Veno‐Arterial ECMO score severity. Conclusions: Women who underwent ECPR had higher in‐hospital mortality rates regardless of the severity of their Survival After Veno‐Arterial ECMO scores, despite the absence of significant sex differences in VA‐ECMO mortality. This emphasizes the necessity for sex‐based strategies in ECPR administration.
- 1 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (13) , e039541
Open AccessSex Differences in In‐Hospital Mortality Among Patients Receiving Veno‐Arterial Extracorporeal Membrane Oxygenation and Extracorporeal Cardiopulmonary Resuscitation: A Propensity Score‐Matched Analysis
Background: Veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) is used in cardiogenic shock, but sex‐specific outcomes remain unclear. This study investigated in‐hospital mortality differences by sex among patients receiving extracorporeal cardiopulmonary resuscitation (ECPR). Methods: We retrospectively reviewed adults with cardiogenic shock treated with VA‐ECMO at National Taiwan University Hospital between 2010 and 2021. After propensity score matching to improve comparability between groups, survival outcomes were assessed using Kaplan‐Meier estimates, and Cox proportional hazards models were used to evaluate the effect of sex on in‐hospital mortality. Results: Of the 1329 patients (average age: 57.1±15.0 years; 953 men), 670 underwent VA‐ECMO for ECPR. Women in the VA‐ECMO group exhibited a lower prevalence of out‐of‐hospital cardiac arrest (6.7% versus 10.7%, P =0.031), a lower body mass index (24.0±4.4 versus 25.0±4.3, P P =0.017) and coronary artery disease (20.9% versus 28.6%, P =0.005) after propensity score matching. No discernible sex differences were observed in the baseline characteristics of the ECPR subgroup. Kaplan‐Meier analyses showed no significant sex differences in mortality for VA‐ECMO (log‐rank P =0.1), but significant disparities were noted for ECPR (log‐rank P =0.006). In the ECPR group, female patients exhibited higher mortality rates compared with men (hazard ratio, 1.37 [95% CI, 1.09–1.72]; P =0.007), independent of Survival After Veno‐Arterial ECMO score severity. Conclusions: Women who underwent ECPR had higher in‐hospital mortality rates regardless of the severity of their Survival After Veno‐Arterial ECMO scores, despite the absence of significant sex differences in VA‐ECMO mortality. This emphasizes the necessity for sex‐based strategies in ECPR administration.
- Open Access
- 10 June 2025
- Published by Elsevier in JACC: Asia
- Vol. 5 (8) , 966-978
Interpretable Independent Recurrent Networks for Forecasting Stroke in Atrial Fibrillation
- 10 June 2025
- Published by Elsevier in JACC: Asia
- Vol. 5 (8) , 966-978
Open AccessInterpretable Independent Recurrent Networks for Forecasting Stroke in Atrial Fibrillation
- Open Access
- 2 December 2024
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 125 (1) , 58-65
Long-term results of stereotactic arrhythmia radioablation for refractory ventricular Arrhythmias—A Taiwanese population study
- 2 December 2024
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 125 (1) , 58-65
Open AccessLong-term results of stereotactic arrhythmia radioablation for refractory ventricular Arrhythmias—A Taiwanese population study
- Open Access
- 19 November 2024
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (2) , 129-138
Phenotypes of atrial fibrillation in a Taiwanese longitudinal cohort: Insights from an Asian perspective
- 19 November 2024
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (2) , 129-138
Open AccessPhenotypes of atrial fibrillation in a Taiwanese longitudinal cohort: Insights from an Asian perspective
- 9 October 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (7) , 1929-1937
Long-Term Glycemic Variability Predicts Adverse Outcomes in Diabetic Heart Failure With Preserved Ejection Fraction
Context: Previous studies have shown associations between glycemic variability (GV) and cardiovascular outcomes in patients with type 2 diabetes. However, the effect of GV on outcomes in diabetic patients with heart failure with preserved ejection fraction (HFpEF) has not been investigated. Objective: To investigate the association between increased GV and cardiovascular outcomes in diabetic patients with HFpEF. Methods: Between 2014 and 2019, we conducted a retrospective cohort analysis using the electronic medical records of a tertiary medical center in Taiwan. Diabetic patients with HFpEF were enrolled. Each individual's coefficient of variability of fasting glucose (FGCV) was determined and the FGCVs were categorized into tertiles. Multivariable Cox regression models and the Kaplan-Meier with log-rank test were used to assess the association between the FGCV and the risk of hospitalization for heart failure (HHF), atrial fibrillation (AF), cardiovascular mortality, and overall mortality. Results: In a cohort comprising 74 835 individuals diagnosed with diabetes, a subset of 753 patients was identified with HFpEF and measurement of FGCV. The median follow-up duration was 38.1 months. In the model of full adjustment, the third FGCV tertile was statistically significantly associated with an increased risk of HHF compared to the first tertile (hazard ratio [HR] = 1.32; 95% CI, 1.04-1.69; P = .025). Likewise, the highest FGCV tertile was associated with an increased risk of death (HR 1.65; 95% CI, 1.16-2.35; P = .005), whereas it was not associated with increased of AF and cardiovascular mortality. Kaplan-Meier analyses revealed a statistically significant association between FGCV and both HHF and overall mortality (log-rank P = .022 and <.001, respectively). Conclusion: Our study highlights a significant association between increased GV and a higher incidence of HHF as well as an elevated overall mortality rate in individuals with diabetes and HFpEF.
- 9 October 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (7) , 1929-1937
Long-Term Glycemic Variability Predicts Adverse Outcomes in Diabetic Heart Failure With Preserved Ejection Fraction
Context: Previous studies have shown associations between glycemic variability (GV) and cardiovascular outcomes in patients with type 2 diabetes. However, the effect of GV on outcomes in diabetic patients with heart failure with preserved ejection fraction (HFpEF) has not been investigated. Objective: To investigate the association between increased GV and cardiovascular outcomes in diabetic patients with HFpEF. Methods: Between 2014 and 2019, we conducted a retrospective cohort analysis using the electronic medical records of a tertiary medical center in Taiwan. Diabetic patients with HFpEF were enrolled. Each individual's coefficient of variability of fasting glucose (FGCV) was determined and the FGCVs were categorized into tertiles. Multivariable Cox regression models and the Kaplan-Meier with log-rank test were used to assess the association between the FGCV and the risk of hospitalization for heart failure (HHF), atrial fibrillation (AF), cardiovascular mortality, and overall mortality. Results: In a cohort comprising 74 835 individuals diagnosed with diabetes, a subset of 753 patients was identified with HFpEF and measurement of FGCV. The median follow-up duration was 38.1 months. In the model of full adjustment, the third FGCV tertile was statistically significantly associated with an increased risk of HHF compared to the first tertile (hazard ratio [HR] = 1.32; 95% CI, 1.04-1.69; P = .025). Likewise, the highest FGCV tertile was associated with an increased risk of death (HR 1.65; 95% CI, 1.16-2.35; P = .005), whereas it was not associated with increased of AF and cardiovascular mortality. Kaplan-Meier analyses revealed a statistically significant association between FGCV and both HHF and overall mortality (log-rank P = .022 and <.001, respectively). Conclusion: Our study highlights a significant association between increased GV and a higher incidence of HHF as well as an elevated overall mortality rate in individuals with diabetes and HFpEF.